Recursion Pharmaceuticals appointed former FDA principal deputy commissioner Namandjé Bumpus, PhD, and Elaine Sun, the COO and CFO of Mammoth Biosciences, to its board of directors. CAMP4 Therapeutics ...

Please visit San Francisco City Hall Events for questions about space rental at City Hall for private events. Wheelchair-accessible entrances are located on Van Ness Avenue and Grove Street. Please ...

On Friday evening, manager Brandon Hyde announced that right-handers Grayson Rodriguez (right triceps/back of elbow) and Andrew Kittredge (left knee) will both be placed on the injured list to begin ...

Gary Miller/Getty Michelle Rodriguez is all about strong vibes. The actress, 46, born and raised in San Antonio, was inducted into the Texas Film Awards Hall of Fame in Austin on March 6.

SARASOTA, Fla. — Starter Grayson Rodriguez and reliever Andrew Kittredge will miss the Baltimore Orioles' opener because of injuries. Orioles manager Brandon Hyde tells reporters that Rodriguez ...

The Orioles will be without yet another player come Opening Day with Grayson Rodriguez expected to miss the start of the season. Orioles manager Brandon Hyde announced Friday that Rodriguez ...

Paolo Bicchieri is the associate editor for the Northern California and Pacific Northwest region writing about restaurant and bar trends, coffee and cafes, and pop-ups. The Michelin Guide ...

LAKELAND, Fla. – The latest injury updates from the Orioles apparently will keep starter Grayson Rodriguez and reliever Andrew Kittredge away from the Opening Day roster. A drama-free camp has ...

The Baltimore Orioles' pitching depth will be tested to start the season. Right-hander Grayson Rodriguez and reliever Andrew Kittredge will both open their seasons on the injured list, manager ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...